Mush-rooms are a source of protein, fiber, B vitamins, selenium, potassium, copper, vitamin D, and numerous polysaccharides and polysaccharide-protein complexes that are believed to enhance both the innate (short term) and adaptive (longer-term) immune response. The functional mush-rooms used to produce PsyKey products contain nutrients with potentially life-changing benefits to the brain, liver, heart, kidneys, and immune system.
Their initial product offering includes three proprietary blends of mush-rooms developed to offer Cognition and memory support, Immune support, and adaptogenic support.
Their products consist of infused coffee blends and capsule supplements. The infused coffee is offered in single-serve coffee pods for easy brew convenience and 12-ounce resealable and vented ground coffee bags.
Their single serve coffee pods are sealed with foil and served in a box of 24 pods. Each pod contains 500mgs of infused functional benefit per serving. The Company’s functional mush-room infused coffees are created by combining the highest quality 100% fair trade organic Arabica coffee beans, with amazing functional mush-rooms that have been used for their benefits for centuries.
PsyKey’s functional coffee formulations are developed utilizing dried ground fruiting body, “Actual Mush-rooms,” intended to provide the full potential of each functional mush-room when brewed.
Game-Changing Partnership With Biotech Company MycoVita
MycoVita is a Biotech company focused on the development of functional foods and products that support optimal health and wellbeing through science-backed formulations and research.
MycoVita holds numerous formulations that are composed of natural occurring compounds sourced only from the highest quality raw ingredients, under the supervision and guidance of its world-class team.
The MycoVita team includes Dr. Omon Isikhuemhen who is an internationally recognized researcher and professor in the field of mush-room science and fungal biotechnology. Dr. Isikhuemhen's credentials include a Bachelor of Science with honors, a Master's of Science in Botany, as well as a Doctor of Philosophy in Microbiology. Dr. Isikhuemhen is a trailblazer in research and development that has resulted in numerous scientific publications and technological advancements.
This strategic partnership will provide PsyKey Inc. exclusive access to formulations, science-backed research, supply chain security, and new potential distribution channels.
"Partnering with MycoVita will not only provide PsyKey the opportunity to offer consumers unmatched quality and efficacy in its product offerings, but it will also open doors in the mush-room industry and mycology world by working alongside Dr. Isikhuemhen. This will allow us to further gain and develop opportunity to provide long-term growth and new revenue streams for the company," said Amar Bhatal, president of PsyKey, Inc.
Read the full partnership article here.
Grab more details at the company website.
-----
And mentioned above, CEOS has several potential catalysts to be aware of right now. They are:
No. 1 CEOS Potential Catalyst - Coffee Line Final Production + New Website/E-commerce Platform
PsyKey Inc. Introduces Its Premium Functional Mush-room Infused Coffee Line to the $8Bn Dollar Functional Mush-room Market, Through the Launch of Its New E-Commerce Website
CARSON CITY, NV / ACCESSWIRE / June 14, 2022 / CECORS, INC. (OTC PINK:CEOS) ("CeCors", "PsyKey" or the "Company") is excited to announce it has completed the final production of its premium functional mush-room-infused coffee line and will launch its highly anticipated products in tandem with its new website and integrated e-commerce platform. The launch of the website will occur on Monday, June 20th, 2022.
According to a report published by Allied Market Research, the global functional mush-room market generated $7.98Bn in 2020 and is estimated to reach $19.33Bn by 2030, witnessing a CAGR of 9.3% from 2021 to 2030.
...
In conjunction with the completion of production, the Company will launch its new evolutionary website and direct-to-consumer e-commerce platform. During the development and production stages, the Company identified and engaged numerous distribution channels and potential key partnerships to support sales and build brand awareness. Initial product offerings will be available via the Company's e-commerce website, with additional distribution announcements soon to come.
"This has been an incredible journey from concept to commercialization. We can stand behind the quality and functionality of our first product offering with our premium single-serve coffees, which is the first in our brand portfolio," stated president Mr. Amar Bhatal. "We have taken our time to make sure that this coffee not only works, functionally but provides an incredible taste, something that stands out in the market. This is the first set of offerings in the portfolio - we have been developing other, various unique delivery systems for our proprietary formulations that we would look forward to offering to our consumers. A very exciting time to be a PsyKey shareholder," continued Mr. Bhatal.
Read the full article here.
-----
No. 2 CEOS Potential Catalyst - Huge Acquisition Has Flown Under-The-Radar
PsyKey Expands Product Portfolio in the $8Bn Dollar Functional Mush-room Market with the Acquisition of NutraRox
CARSON CITY, NV / ACCESSWIRE / March 7, 2022 / CECORS, INC. (OTC PINK:CEOS) ("CeCors", "PsyKey" or the "Company"). is pleased to announce that through a non-dilutive restricted st-ock transaction, the company has acquired 100 percent of Nutra-Rox LLC, specializing in products featuring functional carbonated crystal delivery technology (Think "Pop Rocks" like candy). Nutra-Rox formulates and manufactures innovative consumer products utilizing this patent-pending delivery technology for nutraceuticals and bioactive ingredients. Under the terms of the acquisition agreement, Nutra-Rox shareholders will be subject to a 2-year regulatory hold.
Nutra-Rox delivery technology allows for bioavailable ingredients such as functional mush-rooms delivered via carbonated crystals, that create a multi-sensory sensation in the mouth which provides an unmatched user experience. With the massive popularity of "enjoyable to use" delivery systems such as gummy and candy supplements and vitamins, this novel technology provides the company a unique delivery system in the fast-evolving functional mush-room and innovative wellness markets. The Nutra-Rox acquisition will help increase shareholder value by providing the company expanded novel product offerings, sales, and distribution.
The Nutra-Rox management team has over 50 years of collective experience in research, product development, manufacturing, branding, marketing, sales and distribution. Nutra-Rox is also the parent company of Breath Rox®, a sugar free "popping" fresh breath treatment which delivers zinc gluconate to help reduce odor causing bacteria in the mouth. Breath Rox® has been sold on HSN (Home Shopping Network), online, and continues to pursue additional distribution opportunities including retail and international markets.
"We're excited and eagerly looking forward to the future with this acquisition," said Amar Bhatal president of PsyKey. "We feel the Nutra-Rox teams' diverse expertise and innovative product development capabilities, will serve as a powerful catalyst in helping PsyKey achieve its goals of increasing shareholder value, while becoming a standout innovative wellness company."
Nutra-Rox CIO David Anderson who has managed the company's efforts over the last two years on HSN stated, "We've witnessed the excitement consumers express when using a popping crystal product, as it's fun, different and most importantly, effective." Mr. Anderson continued, "Having worked with our visionary executives for over 20 years, I can see this new venture allowing the company to achieve tremendous success. Our team is currently working on several new formulas which will be released in the coming weeks."
...
Read the full article here.
-----
No. 3 CEOS Potential Catalyst - Company Achieves Key Revenue Milestone
PsyKey, Inc., Achieves Key Revenue Milestone With Purchase Order Of Its Functional Mush-room Products
CARSON CITY, NV / ACCESSWIRE / January 12, 2022 / CECORS, INC. (OTC PINK:CEOS) ("CeCors" or the "Company "), through its wholly-owned subsidiary PsyKey Inc. is pleased to announce its first purchase order in the amount of $50k of its functional mush-room-infused coffee line, from innovative marketing firm "Union Marketing."
"This purchase order demonstrates the dedicated work our team has put into not only developing tasty functional coffees but also to our desire for PsyKey's products to stand out and be noticed. We are confident this purchase order will be the first of many to go in line with our nearing e-commerce launch. These steps and milestones will help us to meet our goal of generating ongoing revenue, and working toward getting the shell status removed from the Company," said Amar Bhatal...
...
"What stemmed from a tenant/landlord relationship has now blossomed into an exciting new opp. We have had the opp. to try some of the upcoming products and were very impressed. We believe this is an opp. for us to develop a subscription model with PsyKey for our over 750,000 members and their families. The functionality of the products is exciting especially when looking at boosting workplace productivity and employee satisfaction," said Tim Hirasawa Chief Financial Officer of Union Marketing.
Read the full article here.
-----
No. 4 CEOS Potential Catalyst - An Explosive Chart History Screams Breakout Potential
On multiple occasions over the past year, CEOS has proven to be an intraday and/or short term breakout star.
Here's a quick rundown:
11/26/21: CEOS blazed a path from an open of $.0413 to a high of $.068. That move resulted in an intraday surge of 64%.
1/5/22: From an open of $.06, CEOS shot to a high of $.108. That's an intraday 80% run.
2/9/22: CEOS opened at $.0796 and cruised to a high of $.139. Yup. That's 74% intraday.
6/3/22: Most recently, CEOS dropped to a low of $.0505 on June 3rd only to rise to a high of $.077 the following session. Overall, that short term run resulted in CEOS cruising 52%.
The proof is in the pudding on this one. Just take a look at its chart. These breakout percentages are not made up.
-----
No. 5 CEOS Potential Catalyst - A Potential Squeeze Near Term? Moving Averages To Track
Since July 5th, CEOS appears to be heating up.
So much so that as of close Thursday, CEOS had pushed above several key lines of potential support.
Those include CEOS's:
- 5-Day Simple Moving Average (SMA)
- 20-Day SMA
- 50-Day SMA
- 5-Day Exponential Moving Average (EMA)
- 13-Day EMA
That's great and all, but here's the key detail to pay attention to.
As of close Thursday, CEOS had a 200-Day SMA of right around $.066.
With so much potential support just below CEOS, there may be little resistance towards a return to its 200-Day SMA!
So what might happen if CEOS breaks through its 200-Day SMA? If that happens, there may be very little resistance for CEOS to revisit previous highs.
Keep a close eye on that 200-Day SMA because if CEOS is able to overtake it, this new breakout idea may be off to the races.
-----
CEOS Recap - Key Potential Catalysts That Could Provide A Breakout Spark
No. 1 - Coffee Line Final Production + New Website/E-commerce Platform
No. 2 - Huge Acquisition Has Flown Under-The-Radar
No. 3 - Company Achieves Key Revenue Milestone
No. 4 - An Explosive Chart History Screams Breakout Potential
No. 5 - A Potential Squeeze Near Term? Moving Averages To Track
-----
Coverage is officially initiated on CEOS. When time permits, do this:
